Inmar Intelligence Healthcare Team | November 5, 2020

DSCSA Mini-Panel: Counterfeit Mitigation

Maintaining patient safety -- through the mitigation of counterfeit medications -- is getting a boost as systemic protective measures are quickly coming online throughout the healthcare ecosystem. However, while serialization will eventually enable the validation of saleable products, the threat to public health from fraudulent drugs has hardly disappeared. Watch this video with industry experts from Inmar for a brief take on the current situation.

 

Inmar Intelligence Healthcare Team